Oncotelic Therapeutics, Inc.
Ticker: 908259
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY2023 | Q3 FY2023 | Q2 FY2020 |
|---|---|---|---|
| INCOME | |||
| Revenue | 0.07+0.0% | 0.07-95.0% | 1.40 |
| Total Income | 0.07+0.0% | 0.07-95.0% | 1.40 |
| EXPENSES | |||
| Expenditure | 0.06+0.0% | 0.06-95.7% | 1.39 |
| PROFIT | |||
| Net Profit | 0.12+0.0% | 0.12-79.3% | 0.58 |
| KEY METRICS | |||
| OPM % | 20.68% | 20.68%+19.69pp | 0.99% |
| NPM % | 100.00% | 100.00%+58.42pp | 41.58% |
| EPS | 0.00 | 0.00-100.0% | 0.01 |
Corporate Events
No corporate events found.